Document is current
Any future updates will be listed below
-
Authors
Nieuwdorp, Max
Herrema, Hilde
- License Information
-
More Information
Article History
First Online: 17 October 2022
Competing interests
: M.N. is founder and member of the Scientific Advisory Board of Caelus Pharmaceuticals, the Netherlands, which has no direct relation to the outcomes of this study. H.H. declares no competing interests.
